Elicio Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -2.79%
- Market cap
- $44.44M
- 28.31M shares
- Filings
- 385
Q1 2023−91.9% FY22 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+5.4% FY25 yoy
- $44.44M
- —
- —
- 2.4×
- -83.18%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | $2,301,000 | reported | |
| FY 2021 | 2021-12-31 | $28,312,000 | reported | |
| FY 2020 | 2020-12-31 | $2,880,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | — | $0.00 | $0.00 | — | 15.95M sh | +55.9% | — |
| FY2023 | — | $150.00K | $150.00K | — | 10.23M sh | −66.0% | — |
| FY2022 | — | $0.00 | $0.00 | — | 30.11M sh | +0.5% | — |
Pharmaceutical preparations
Elicio Therapeutics, Inc. is the 339th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
GANXGain Therapeutics, Inc.———$48.1MHYFTMindWalk Holdings Corp.———$46.9MPLRXPliant Therapeutics, Inc.$0.0——$45.9MATNMActinium Pharmaceuticals, Inc.$90.0K—37,652.2%$44.8M
ELTXElicio Therapeutics, Inc. (this company)———$44.4M
CNTBConnect Biopharma Holdings Ltd$64.0K99.8%86,687.5%$43.0MDWTXDogwood Therapeutics, Inc.———$42.1MIBOImpact Biomedical Inc.$32.0K—36,993.8%$41.5MBMEABiomea Fusion, Inc.———$41.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Elicio Therapeutics, Inc. · CIK 1601485 · Engraved from SEC EDGAR